F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma

Clinical Nuclear Medicine

Volumn 23, Issue 9, 1998, Pages 604-608

  Bakheet, Siema M ^a   Powe, John ^a   Ezzat, Adnan ^a   Al Suhaibani, Hamad ^a   Tulbah, Asma ^a   Rostom, Assem ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Breast Sarcoma; F 18 FDG Positron Emission Tomographic Scan; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; BREAST SARCOMA; CANCER DIAGNOSIS; CANCER RECURRENCE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSARCOMA PHYLLOIDES; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; RHABDOMYOSARCOMA;

ADOLESCENT; ADULT; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHYLLODES TUMOR; RADIOPHARMACEUTICALS; RHABDOMYOSARCOMA, ALVEOLAR; SARCOMA; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031658722     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199809000-00009     Document Type: Article

References (5)

1. Nieweg OE, Wong WH, Singletary SE, Hortobagyi GN, Kim EE: Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy. Ann N Y Acad Sci 693:423, 1993.
2. Podoloff DA: The role of radionuclide scans in sarcoma. Hematol Oncol Clin of North Am 9:605, 1995.
3. Moore MP, Kinne DW: Breast sarcoma. Surg Clin North Am 76:383, 1996.
4. Rosen PP, Oberman HA: Tumors of the mammary gland. In: Rosen PP, Oberman HA, eds. Atlas of Tumor Pathology. Washington DC: Armed Forces Institutes of Pathology, 1993: 315.
5. Hawkins R, Hoh CK: FDG PET studies in oncology. Nucl Med Biol 21:739, 1994.